# Wegovy Tablet vs Injection: What an Indirect Trial Comparison Found | Buy This GLP

An indirect analysis linked STEP 1 and OASIS 4 to estimate the weight-loss difference between the Wegovy tablet and injection. See what it can show.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/the-tablet-matched-the-injection-indirectly
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Formats

# Wegovy Tablet vs Injection: What an Indirect Trial Comparison Found

An analysis compared the 25 mg tablet with the 2.4 mg injection through separate placebo trials. The estimated difference was small and uncertain.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Estimated weight-loss advantage for injection · no difference · 1.01 · −1.61 · 3.63 · Nobody was randomized between the two products. · Two separate trials, bridged statistically.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   Researchers compared the 25 mg semaglutide tablet and 2.4 mg injection indirectly through separate placebo-controlled trials.
-   The estimated weight-loss difference was 1.01 percentage points in favor of the injection.
-   The confidence interval included a small advantage for either formulation.

Researchers used two placebo trials to estimate a difference between Wegovy tablets and injections [\[1\]](https://buythisglp.com/research/the-tablet-matched-the-injection-indirectly#ref-1). Our [guide to oral and injected semaglutide doses](https://buythisglp.com/research/oral-semaglutide-dose-vs-injection) explains what each trial measured. No participants were randomly assigned between the two formulations in this analysis.

## How the comparison worked

OASIS 4 tested the 25 mg daily tablet against oral placebo. STEP 1 tested the 2.4 mg weekly injection against injectable placebo. Researchers used the placebo arms as a common reference [\[1\]](https://buythisglp.com/research/the-tablet-matched-the-injection-indirectly#ref-1). The analysis depends on how comparable the trials and their participants were.

## What the numbers show

The estimated weight-loss difference favored the injection by 1.01 percentage points [\[1\]](https://buythisglp.com/research/the-tablet-matched-the-injection-indirectly#ref-1). The 95% confidence interval ran from −1.61 to 3.63 points. A second analysis assuming adherence favored the injection by 0.55 points, with a 95% confidence interval from −2.25 to 3.35. Both intervals leave room for a small advantage in either direction.

Novo Nordisk, the maker of Wegovy, funded this indirect comparison. A [price comparison for GLP-1 pills and injections](https://buythisglp.com/research/is-the-glp1-pill-cheaper-than-the-injection) is useful only when the products and terms are clear. This analysis does not establish therapeutic equivalence or extend to other formulations.

## Frequently asked

Did the study compare Wegovy tablets and injections directly?

No. It used placebo arms from two separate trials as a common reference.

How large was the estimated difference?

Weight loss favored injection by 1.01 percentage points. The 95% confidence interval from −1.61 to 3.63 points allows a small advantage in either direction.

Does this establish that the formulations are equivalent?

The study estimates a difference indirectly. Differences between trials still matter, and the authors did not randomize participants between formulations.

## Sources

1.  \[1\] Plotkin M, Ivkovic M, Smith I, Rathor N, Chowdhury R, Hodkinson A (2026). Semaglutide 25 mg Oral Versus Semaglutide 2.4 mg Injectable: An Indirect Treatment Comparison of Weight Loss Outcomes Diabetes, Obesity & Metabolism. [PMID 42225300](https://pmc.ncbi.nlm.nih.gov/articles/PMC13341388/)

## Where to get it

### Price the oral sellers

Switch the desk to tablets and it prices the oral product itself, never a figure borrowed from the same seller's injection page.

[Open the price desk →](https://buythisglp.com/)

## More in Formats

-   [
    
    Foundayo: compare the whole bill · Prescribed tablet and strength · Clinical visits or membership · Next refill and offer conditions
    
    ### Orforglipron (Foundayo): What to Check Before Buying
    
    ](https://buythisglp.com/research/orforglipron-foundayo-buying-guide)
-   [
    
    HSA / FSA payment · Prescription · itemized bill · receipt
    
    ### Can You Use HSA for Semaglutide? What to Keep Before Paying
    
    ](https://buythisglp.com/research/can-you-use-hsa-for-semaglutide)
-   [
    
    Cash price ≠ credited claim · Ask before paying, then check the claim
    
    ### Does Cash Pay Medication Count Toward Your Deductible? GLP-1 Rules
    
    ](https://buythisglp.com/research/does-cash-pay-medication-count-toward-deductible)
